OB/GYN · Outcome measure

Pelvic Floor Impact Questionnaire

The Pelvic Floor Impact Questionnaire-7 (PFIQ-7) is a validated, condition-specific quality-of-life measure for women with pelvic floor disorders. It captures how urinary, bowel, and pelvic organ prolapse symptoms affect daily activities, physical function, and emotional health across three parallel scales, giving clinicians a concise snapshot of symptom burden and how it changes over time.

Why healthcare providers use the PFIQ-7

  • Quantifies quality-of-life impact. It turns a patient's experience of pelvic floor symptoms into a numeric score that can be documented and compared.
  • Tracks treatment response. Repeating the measure before and after pelvic floor therapy, a pessary, or surgery shows whether symptom impact is improving.
  • Covers three symptom domains. Urinary, colorectal-anal, and prolapse impact are scored separately, so you can see which domain drives a patient's burden.
  • Supports shared decision-making. A concrete score gives patients and clinicians a common reference point when weighing conservative and surgical options.

Which settings use the PFIQ-7?

  • Urogynecology clinics. Specialists use it to characterize baseline burden and measure outcomes across the full range of pelvic floor conditions.
  • OB/GYN practices. General gynecology teams screen for and follow the impact of incontinence and prolapse during routine care.
  • Pelvic floor physical therapy. Therapists use serial scores to document functional progress across a course of treatment.
  • Continence and colorectal clinics. Teams managing bladder and bowel dysfunction rely on the colorectal-anal and urinary scales.

What does the PFIQ-7 measure?

The PFIQ-7 asks the same seven questions about how pelvic floor symptoms affect household chores, physical activity, travel, social life, and emotional well-being, and the patient answers them three times, once for each symptom domain. This produces three parallel scales:

  • Urinary Impact Questionnaire (UIQ). The impact of bladder and urinary symptoms on daily life.
  • Colorectal-Anal Impact Questionnaire (CRAIQ). The impact of bowel and anal symptoms, including fecal incontinence.
  • Pelvic Organ Prolapse Impact Questionnaire (POPIQ). The impact of prolapse and related pelvic pressure symptoms.

Scoring the PFIQ-7

  • Number of items. Seven questions answered separately for each of three scales, for 21 responses in total.
  • Per-item scale. Each response ranges from 0 (not at all) to 3 (quite a bit).
  • Total score range. Each scale is averaged and rescaled to 0 to 100, and the three scale scores are summed for a total from 0 to 300.
  • Score direction. Higher scores indicate greater impact on quality of life; a score of 0 means no impact.

The PFIQ-7 has no official severity bands, so the total is not sorted into mild, moderate, or severe categories. The score guides clinical decision-making as a measure of self-reported burden and is most useful when interpreted alongside the exam, symptom history, and each patient's goals rather than as a standalone threshold.

For tracking change, the original validation work suggested that a decrease of roughly 36 points (about 12 percent of the range) represents a clinically meaningful improvement after surgery. Use change over repeated administrations, rather than a single value, to judge whether symptom impact is improving.

Best practices for administration

  • Establish a baseline. Administer the PFIQ-7 at the first visit so later scores have a clear reference point.
  • Re-administer consistently. Repeat the questionnaire at consistent intervals and after interventions to make change over time interpretable.
  • Encourage complete answers. Remind patients to answer all seven questions for each relevant scale, since scale scores rely on the mean of completed items.
  • Offer privacy. The questions cover sensitive bladder, bowel, and prolapse symptoms, so let patients complete it privately whenever possible.
  • Pair with symptom measures. Combining the impact score with a symptom inventory gives a fuller picture of both severity and burden.

How Zentake helps with the PFIQ-7

  • Automatic scoring. Zentake calculates each scale and the total on submit, so staff never hand-tally responses.
  • Longitudinal tracking. Re-send the measure on a schedule and view how a patient's scores change over time.
  • Before the visit. Patients complete the PFIQ-7 from home on any device, so scores are ready before the appointment for OB/GYN practices.
  • HIPAA compliant. Responses are encrypted, with a signed BAA on every plan.

References

Barber MD, Walters MD, Bump RC. Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). American Journal of Obstetrics and Gynecology. 2005;193(1):103-113. This is the primary validation study, which reported the scale structure, scoring, and the clinically meaningful change estimate.

Additional scoring and psychometric detail is summarized by the Shirley Ryan AbilityLab Rehabilitation Measures Database and by Physiopedia, which confirm the 0 to 300 total range and the three-scale structure.

Last updated: August 2026

Frequently asked

Pelvic Floor Impact Questionnaire-7 questions, answered.

What is the PFIQ-7 used for?

The PFIQ-7 measures how pelvic floor symptoms affect a woman's quality of life, daily activities, and emotional health. Clinicians use it to quantify symptom burden from urinary incontinence, bowel dysfunction, and pelvic organ prolapse, and to track how that burden changes after treatment such as pelvic floor therapy or surgery.

How is the PFIQ-7 scored?

Each of the 7 questions is answered separately for three scales, urinary, colorectal-anal, and prolapse, using a 0 to 3 response. Each scale is averaged, multiplied by 100 and divided by 3 for a 0 to 100 score. The three scale scores are summed for a total from 0 to 300.

What is a good PFIQ-7 score?

Lower scores are better, with 0 meaning symptoms cause no impact on quality of life. There is no universal severity cutoff. Instead, clinicians interpret each patient's score in context and watch for change over time, since a decrease of roughly 36 points was suggested as clinically meaningful after surgery.

Who completes the PFIQ-7?

The patient completes the PFIQ-7 as a self-report questionnaire. It was validated in women aged 18 and older with pelvic floor disorders, including urinary incontinence, fecal incontinence, and pelvic organ prolapse. No clinician training is required, and most patients finish it in a few minutes.

How often should the PFIQ-7 be administered?

Many practices administer the PFIQ-7 at the initial visit to establish a baseline, then repeat it after an intervention such as pelvic floor physical therapy, a pessary, or surgery. Re-administering on a consistent schedule lets you compare scores and document whether symptom impact is improving over time.

Is the PFIQ-7 free to use?

Yes. The PFIQ-7 was developed by Barber and colleagues and is freely available for clinical and research use without licensing fees. It is a shortened form of the original 31-item questionnaire, designed to reduce patient burden while retaining strong correlation with the long version.

In Zentake

Send the Pelvic Floor Impact Questionnaire-7 in three clicks.

From sending to scoring to chart write-back. No manual math, no transcription, no PDF wrangling.